Skip to main content

Table 3 Hemagglutination Inhibition (HAI) antibody titers after trivalent adjuvanted inactivated influenza vaccine (aIIV3) and trivalent high-dose inactivated influenza vaccine (HD-IIV3) for each influenza vaccine strain by age for 2017–2018 and 2018–2019 influenza seasons

From: Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

65–79 Years

 

aIIV3 Group

HD-IIV3 Group

aIIV3–HD-IIV3

Strain

 

Time

N

Value

95% CI

N

Value

95% CI

Difference 95% CI

 H1N1

GMTa

Day 1d

269

52.5

(44.3, 62.2)

261

49.5

(41.4, 59.0)

0.03 (-0.08, 0.13)

 

Day 29

269

108.8

(92.1, 128.5)

261

100.9

(84.9, 119.9)

0.03 (-0.07, 0.14)

%SPb

Day 1

188

69.9

(64.0, 75.3)

171

65.5

(59.4, 71.2)

4.37 (-3.59, 12.33)

 

Day 29

225

83.6

(78.7, 87.8)

216

82.8

(77.6, 87.1)

0.88 (-5.48, 7.25)

%SCc

Day 29

80

29.7

(24.3, 35.6)

71

27.2

(21.9, 33.0)

2.54 (-5.14, 10.22)

 H3N2

GMT

VDay 1

269

63.3

(51.7, 77.5)

261

56.4

(45.5, 69.8)

0.05 (-0.08, 0.18)

 

Day 29

269

145.3

(124.3, 169.7)

261

184.4

(155.2, 219.1)

-0.10 (-0.20, -0.00)

%SP

Day 1

181

67.3

(61.3, 72.8)

171

65.5

(59.4, 71.2)

1.77 (-6.27, 9.81)

 

Day 29

246

91.4

(87.4, 94.4)

230

88.1

(83.6, 91.7)

3.33 (-1.83, 8.48)

%SC

Day 29

92

34.2

(28.5, 40.2)

103

39.5

(33.5, 45.7)

-5.26 (-13.47, 2.94)

 Influenza B

GMT

Day 1

269

12.2

(10.8, 13.8)

261

11.8

(10.3, 13.4)

0.02 (-0.06, 0.09)

 

Day 29

269

20.3

(17.2, 24.1)

261

23.8

(20.0, 28.4)

-0.07 (-0.17, 0.04)

%SP

Day 1

60

22.3

(17.5, 27.8)

52

19.9

(15.3, 25.3)

2.38 (-4.56, 9.33)

 

Day 29

114

42.4

(36.4, 48.5)

118

45.2

(39.1, 51.5)

-2.83 (-11.28, 5.61)

%SC

Day 29

51

19.0

(14.5, 24.2)

68

26.1

(20.8, 31.8)

-7.09 (-14.19, -0.00)

80 years and older

 H1N1

GMTa

Day 1d

73

49.3

(35.1, 69.3)

77

55.6

(39.2, 78.8)

-0.05 (-0.26, 0.16)

 

Day 29

73

73.4

(55.2, 97.7)

77

88.7

(66.7, 118.0)

-0.08 (-0.25, 0.09)

%SPb

Day 1

50

68.5

(56.6, 78.7)

55

71.4

(60.0, 81.0)

-2.94 (-17.61, 11.74)

 

Day 29

60

82.2

(71.5, 89.9)

66

85.7

(75.9, 92.4)

-3.52 (-15.27, 8.23)

%SCc

Day 29

16

21.9

(13.1, 33.1)

19

24.7

(15.6, 35.8)

-2.76 (-16.28, 10.76)

 H3N2

GMT

Day 1

73

63.7

(41.4, 98.0)

77

66.5

(43.9, 101)

-0.02 (-0.27, 0.24)

 

Day 29

73

129.2

(93.4, 178.8)

77

155.0

(114.2, 210.5)

-0.08 (-0.27, 0.11)

%SP

Day 1

47

64.4

(52.3, 75.1)

51

66.2

(54.6, 76.5)

-1.85 (-17.09, 13.39)

 

Day 29

61

83.6

(73.0, 91.0)

69

89.6

(80.6, 95.2)

-6.05 (-16.95, 4.85)

%SC

Day 29

20

27.4

(17.6, 39.1)

27

35.1

(24.5, 46.7)

-7.67 (-22.44, 7.11)

 Influenza B

GMT

Day 1

73

18.7

(14.6, 24.0)

77

31.2

(23.2, 42.1)

-0.22 (-0.39, -0.05)

 

Day 29

73

27.0

(19.0, 38.2)

77

45.0

(31.8, 63.5)

-0.22 (-0.43, -0.01)

%SP

Day 1

24

32.9

(22.3, 44.8)

39

50.6

(39.0, 62.2)

-17.77 (-33.29, -2.25)

 

Day 29

37

50.7

(38.7, 62.5)

47

61.0

(49.2, 71.8)

-10.35 (-26.17, 5.46)

%SC

Day 29

13

17.8

(9.8, 28.5)

11

14.3

(7.4, 24.1)

3.52 (-8.23, 15.27)

  1. a GMT: Geometric mean titers
  2. b % SP: Percent Seropositive, defined as HAI titer ≥ 1:40
  3. c % SC: Percent Seroconversion, defined as an HAI titer ≥ 1:40 at day 29 post-vaccination if the baseline pre-vaccination titer is < 1:10 or a minimum four-fold rise in HAI titer if the baseline pre-vaccination titer is ≥ 1:10
  4. d Day 1: Baseline blood draw before vaccination; Day 29 blood draw on 29 ± 7 days post-vaccination